Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions

Abstract

S evere acute respiratory syndrome coronavirus (SARS-CoV) 2, is a readily transmissible zoonotic pathogen and the etiologic agent of the coronavirus disease (COVID-19) pandemic (1).To determine aerosol stability of the virus, we measured the dynamic (short-term) aerosol efficiencies of SARS-CoV-2 and compared its efficiency with those of SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV). The StudyWe analyzed these 3 viruses' dynamic aerosol efficiencies using 3 nebulizers, the Collison 3-jet (C3), Collison 6-jet (C6) (http://www.chtechusa.com), and Aerogen Solo (AS) (https://www.aerogen.com),to generate viral aerosols (Appendix, https://wwwnc.cdc.

References 15

1. 1.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

2. 2.
   Influenza Virus Aerosols in Human Exhaled Breath: Particle Size, Culturability, and Effect of Surgical Masks · 2013

   No notice
3. 3.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

4. 4.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

5. 5.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

6. 6.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

7. 7.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

8. 8.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

9. 9.
   Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States · 2020

   No notice
10. 10.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

11. 11.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

12. 12.
    SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat · 2020

    No notice
13. 13.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

14. 14.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

15. 15.
    The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission · 2020

    No notice

Cited by papers we hold 8

• The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment · 2022
  No notice
• Exhaled aerosol increases with COVID-19 infection, age, and obesity · 2021
  Corrected
• Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols · 2021
  No notice
• Assessing the risk of COVID-19 from multiple pathways of exposure to SARS-CoV-2: Modeling in health-care settings and effectiveness of nonpharmaceutical interventions · 2021
  Not checked
• Factors affecting aerosol SARS-CoV-2 transmission via HVAC systems; a modeling study. · 2021
  Not checked
• Bioseguridad en la atención odontológica a partir de la pandemia COVID-19: un análisis global de las nuevas medidas · 2021
  Not checked
• COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection · 2021
  No notice
• A guideline to limit indoor airborne transmission of COVID-19 · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.